ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,501,167 | -0.8% | 93,084 | +31.7% | 0.01% | 0.0% |
Q2 2023 | $2,520,092 | +40.4% | 70,670 | 0.0% | 0.01% | +50.0% |
Q1 2023 | $1,795,018 | -44.1% | 70,670 | -10.8% | 0.01% | -50.0% |
Q4 2022 | $3,213,488 | +45.1% | 79,228 | +18.3% | 0.01% | +33.3% |
Q3 2022 | $2,214,000 | -6.1% | 66,983 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $2,358,000 | -17.1% | 66,983 | +8.3% | 0.01% | 0.0% |
Q1 2022 | $2,844,000 | -30.6% | 61,836 | 0.0% | 0.01% | -25.0% |
Q4 2021 | $4,100,000 | +1.5% | 61,836 | -4.4% | 0.01% | -7.7% |
Q3 2021 | $4,039,000 | -21.1% | 64,696 | +4.7% | 0.01% | -23.5% |
Q2 2021 | $5,117,000 | +26.3% | 61,781 | +1.1% | 0.02% | +21.4% |
Q1 2021 | $4,051,000 | -18.8% | 61,097 | -6.1% | 0.01% | -22.2% |
Q4 2020 | $4,991,000 | +67.2% | 65,042 | -6.2% | 0.02% | +50.0% |
Q3 2020 | $2,985,000 | -3.0% | 69,321 | -2.7% | 0.01% | -7.7% |
Q2 2020 | $3,076,000 | +70.4% | 71,217 | +13.5% | 0.01% | +44.4% |
Q1 2020 | $1,805,000 | -54.6% | 62,754 | 0.0% | 0.01% | -40.0% |
Q4 2019 | $3,980,000 | +66.7% | 62,754 | -25.9% | 0.02% | +66.7% |
Q3 2019 | $2,387,000 | – | 84,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $20,836,128 | 14.83% |
Aquilo Capital Management, LLC | 1,018,474 | $25,869,240 | 10.72% |
Rokos Capital Management LLP | 1,675,921 | $41,537,702 | 3.07% |
COMMODORE CAPITAL LP | 575,000 | $14,605,000 | 2.22% |
Privium Fund Management B.V. | 259,036 | $6,579,514 | 2.21% |
JOHNSON & JOHNSON | 247,598 | $6,288,989 | 2.05% |
WEALTH EFFECTS LLC | 156,810 | $3,982,976 | 2.04% |
M28 Capital Management LP | 67,400 | $1,711,960 | 1.94% |
Evolutionary Tree Capital Management, LLC | 51,878 | $1,317,701 | 1.83% |
Avidity Partners Management LP | 1,741,300 | $44,229,020 | 1.47% |